Showing 11,401 - 11,420 results of 24,497 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.05s Refine Results
  1. 11401

    Table 1_Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: a test of the polarization hypothesis.docx by Alexander Tran (11038679)

    Published 2025
    “…</p>Methods<p>We obtained data from the Reducing Alcohol Related Harm Standard European Alcohol Survey for Lithuania, for two separate years; 2015 (n = 1354, mean age = 41.04 ± 13.04, females = 680, 50.2%) and 2020 (n = 1015, mean age = 42.27 ± 13.44, females = 513, 50.5%). …”
  2. 11402

    Image 1_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…Our updated analysis confirmed at PC therapy significantly improves OS (hazard ratio [HR]: 0.73 [0.69, 0.77], P < 0.00001), PFS (HR: 0.56 [0.52, 0.60], P < 0.00001), duration of response (DOR, HR: 0.50 [0.45, 0.54], P < 0.00001) and objective response rate (ORR, risk ratio [RR]: 1.59 [1.51, 1.67], P < 0.00001) compared to chemotherapy alone. …”
  3. 11403

    Table 6_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…Our updated analysis confirmed at PC therapy significantly improves OS (hazard ratio [HR]: 0.73 [0.69, 0.77], P < 0.00001), PFS (HR: 0.56 [0.52, 0.60], P < 0.00001), duration of response (DOR, HR: 0.50 [0.45, 0.54], P < 0.00001) and objective response rate (ORR, risk ratio [RR]: 1.59 [1.51, 1.67], P < 0.00001) compared to chemotherapy alone. …”
  4. 11404

    Rice (<i>Oryza sativa</i> L.) developmental stages. by Nathaniel B. Lyman (449148)

    Published 2013
    “…<b>b,</b> Harvest dates are not available for the paddy yield data, so we approximate harvest as 40 days after 50% heading. …”
  5. 11405

    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  6. 11406

    Impact of mepolizumab in patients with high-burden severe asthma within a managed care population by Njira L. Lugogo (13119569)

    Published 2023
    “…Of the 264 patients with ≥1 OCS claim during baseline, 191 (72.3%) showed a decrease in mean daily OCS use by ≥50% in 117 patients (61.3%). …”
  7. 11407

    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  8. 11408

    Representative Proteomes: A Stable, Scalable and Unbiased Proteome Set for Sequence Analysis and Functional Annotation by Chuming Chen (223254)

    Published 2011
    “…One approach to dealing with this problem is to minimize the number of proteins subjected to such analysis in a way that minimizes loss of information. To this end we have developed a set of Representative Proteomes (RPs), each selected from a Representative Proteome Group (RPG) containing similar proteomes calculated based on co-membership in UniRef50 clusters. …”
  9. 11409

    M002 infection and cell survival. by Michael L. Megison (469463)

    Published 2014
    “…After 72 hr of treatment, cell viability was measured with alamarBlue™ assays. Data reported as mean ± standard error of the mean. There was a significant decrease in viability in all cell lines following M002 treatment. …”
  10. 11410

    Telomere shortening culminates in tissue defects associated with aging. by Madalena C. Carneiro (102302)

    Published 2016
    “…Data are represented as mean +/- SEM.</p>…”
  11. 11411

    Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx by Rasita Vinay (21006911)

    Published 2025
    “…Impolite prompting resulted in a significant decrease in disinformation production across all models (davinci-002, 59%; davinci-003, 44%; and gpt-3.5-turbo, 28%) and a slight reduction for gpt-4 (94%).…”
  12. 11412
  13. 11413

    Nav1.7 KOs are insensitive to painful thermal, mechanical, and chemical stimuli. by Jacinthe Gingras (625973)

    Published 2014
    “…(<b>48°C</b>: WT/HET, 42.2 sec ±2.6 sec and KO, 59 sec ±1 sec; <b>50°C</b>: WT/HET 25.2 sec ±1.5 sec and KO, 59 sec ±0.2 sec; <b>52.5°C</b>: WT/HET, 17.7 sec ±1.2 sec and KO, 30 sec ±0 sec; <b>55°C</b>: WT/HET, 6.9 sec ±0.9 sec and KO, 20 sec ±0 sec (mean ± S.E.M., Wilcoxon two-sample exact test, 48°C: p = 4.470 E-08; 50°C: p = 3.806 E-08; 52.5°C: p = 5.956 E-11; 55°C: p = 5.956 E-11). …”
  14. 11414

    Loop C residues modulate activation through a complex network of interactions. by Ákos Nemecz (356830)

    Published 2017
    “…<p>Stick representation of the evaluated Arg, Asp, Glu, and Lys residues are labeled and color coded based upon effect, with Asp/Glu pink residues producing a strong decrease in pH<sub>50</sub> when mutated in combination, and yellow residues producing a nonsignificant or weak effect. …”
  15. 11415

    Treatment of gp130<sup>757FF</sup> mice with WP1066 reduces tumour size. by Louise M. Judd (185660)

    Published 2014
    “…Antral tumours in 8 week untreated mice (A) and 10 week DMSO-treated vehicle controls (B) were no different in mean area, however WP1066 treatment resulted in ∼50% smaller tumours (C). …”
  16. 11416

    Effects of site-specific sustained photostimulation of inhibitory neurons within the pre-Bötzinger complex <i>in situ</i>. by Jessica Ausborn (5147210)

    Published 2018
    “…(<b>D</b>) Summary data (n = 10, mean ± SEM, **p<0.01, *p<0.05) of bilateral pre-BötC photostimulation shows that relatively weak (0.5–2.0 mW) stimulation significantly increased respiratory frequency in a laser power-dependent manner, and stronger (4.0–5.0 mW) stimulation caused a decrease of inspiratory frequency with complete termination of inspiratory activity for the stimulus duration at the maximum laser power (5.0 mW).…”
  17. 11417

    Characterization of phenotypically unique accessions. by Maria Stefania Przybylska (22756354)

    Published 2025
    “…</i></i> common accessions classification. Mean Decrease Accuracy (top) and Mean Decrease Gini (bottom) of the random forest models are presented. …”
  18. 11418

    Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI) by Soili Törmälehto (692961)

    Published 2019
    “…Group-based trajectory modeling was used to identify patterns of experiencing a decrease of ≥10 points (Minimal Important Change, MIC) in the Quality of Life subscale of the Knee injury and Osteoarthritis Outcome Score compared to baseline. …”
  19. 11419

    Decline in SHP2 activity follows decline in ARSB in HepG2 cells and in ARSB-null mice. by Sumit Bhattacharyya (14205)

    Published 2016
    “…<p><b>(A)</b> The SHP2 activity declined ~36% from (2.49 ± 0.15 nmol/mg protein/0.5 h to 1.59 nmol/mg protein/0.5h) following ARSB silencing (p<0.001; n = 6), and increased to 3.70 ± 0.16 nmol.mg protein/0.5h when ARSB was overexpressed in the HepG2 cells (p<0.001; n = 3). …”
  20. 11420

    Calcineurin acts as a Ca<sup>2+</sup> sensor for metamodulation of LP I<sub>h</sub> in 5nM DA. by Wulf-Dieter C. Krenz (693267)

    Published 2015
    “…Black asterisks indicate that a one-way ANOVA on the four DA-treatment groups with Tukey’s post hoc tests that made all pair wise comparisons showed that the decrease observed for the TTX + DA + (+50 OSC) treatment group was significantly different from the other three DA treatment groups, and that those three DA treatment groups [(TTX+DA, TTX+DA+FK506, TTX+DA+FK506+(+50 OSC)] were not significantly different from one another: (F (3,26) = 11.08; p = 0.0001). …”